Neutralizing Monoclonal Antibody Treatment Reduces Hospitalization for Mild and Moderate Coronavirus Disease 2019 (COVID-19): A Real-World Experience
Verderese, John Paul;Stepanova, Maria;Lam, Brian;Racila, Andrei;Kolacevski, Andrej;Allen, David;Hodson, Erin;Aslani-Amoli, Bahareh;Homeyer, Michael;Stanmyre, Sarah;Stevens, Helen;Garofalo, Stephanie;Henry, Linda;Venkatesan, Chapy;Gerber, Lynn H;Motew, Steve J;Jones, J Stephen;Younossi, Zobair M;
clinical infectious diseasespp. -
172
paulclinicalneutralizing
Abstract
In a real-life clinical setting, we found that receipt of neutralizing monoclonal antibody (NmAb) treatment significantly reduced hospital utilization among pat